Journal of Pharmaceutical Research International

Background: Cerebral Palsy can be defined as a cluster of disorders acting on a person’s movement, posture, and balance. Cerebral Palsy, which affects 2 to 3 out of every 1000 live births, is caused by a variety of factors, including brain injury which can affect movement, posture, and balance. It’s linked to the perinatal period in about 92% of cases. Premature birth, perinatal infections, intrauterine growth restrictions, multiple gestations, and other risk factors are all factors to consider. This disorder prevents normal motor function Development. This protocol was developed to describe the design of an interventional study for the evaluation of the effect of Neuro-developmental treatment with conventional therapy and Passive Stretching with conventional therapy on improving posture in diplegic spastic Cerebral Palsy patients.

Methods: Participants (n=70) with spastic diplegic Cerebral Palsy who meet the included criteria will be hired for the study. Patients in group A will receive Neuro-Developmental treatment and conventional therapy, while patients in group B will receive Passive Stretching with conventional therapy. The Treatment protocol will last 6 weeks. Regular evaluations will take place. The Modified Ashworth Scale and the Gross Motor Function Classification System are going to be used to assess our progress.

Discussion: The intervention’s efficacy will be assessed by analyzing gross motor functions with the help of Gross Motor Function Classification System and spasticity level using Modified Ashworth Scale. Study and analysis will significantly support the use of Neuro-Developmental treatment with conventional therapy and Passive Stretching in conjunction with conventional therapy in Cerebral Palsy patients.